Benchmark Starts Bio-Techne Corp. (TECH) at Buy
- S&P 500 hits 2023 closing high as Powell strengthens peak rate bets
- Santa will continue to deliver - Stock Trader's Almanac
- 5 Tesla analysts weigh in as Tesla stock lags after Cybertruck updates
- Shares climb, dollar falls with Fed comments inspiring dovish bets
- Ulta Beauty lifts guidance after Q3 results beat estimates
Benchmark analyst Robert Wasserman initiates coverage on Bio-Techne Corp. (NASDAQ: TECH) with a Buy rating and a price target of $290.00.
Shares of Bio-Techne Corp. closed at $261.83 yesterday.
You May Also Be Interested In
- Goldman Sachs Starts Erste Group Bank (EBS:AV) (EBKDY) at Neutral
- CJS Securities Starts indie Semiconductor Inc (INDI) at Market Outperform
- Jefferies Starts Amdocs Ltd. (DOX) at Buy; 'Software "Glue" Within Telecom Networks'
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!